BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36206160)

  • 21. Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR[BC]).
    Park JY; Lengacher CA; Reich RR; Alinat CB; Ramesar S; Le A; Paterson CL; Pleasant ML; Park HY; Kiluk J; Han H; Ismail-Khan R; Kip KE
    Transl Behav Med; 2019 Jul; 9(4):693-702. PubMed ID: 30137607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Staged Data-Integrated Multi-Omics Analysis for Symptom Science Research.
    Harris CS; Miaskowski CA; Dhruva AA; Cataldo J; Kober KM
    Biol Res Nurs; 2021 Oct; 23(4):596-607. PubMed ID: 33827270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for Simplicity in the Complexity of Symptom Clusters.
    Bellury LM; Clark JC
    Oncol Nurs Forum; 2018 May; 45(3):284-286. PubMed ID: 29683118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A literature review of symptom clusters in patients with breast cancer.
    Nguyen J; Cramarossa G; Bruner D; Chen E; Khan L; Leung A; Lutz S; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):533-9. PubMed ID: 21958098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms and Health-Related Quality of Life in Patients Receiving Cancer Therapy Matched to Genomic Profiles.
    Williams K; Bergquist-Beringer S
    Oncol Nurs Forum; 2018 Nov; 45(6):E125-E136. PubMed ID: 30339156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer.
    Starkweather A; Kelly DL; Thacker L; Wright ML; Jackson-Cook CK; Lyon DE
    Support Care Cancer; 2017 Jan; 25(1):167-176. PubMed ID: 27599815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom clusters in women with breast cancer: an analysis of data from social media and a research study.
    Marshall SA; Yang CC; Ping Q; Zhao M; Avis NE; Ip EH
    Qual Life Res; 2016 Mar; 25(3):547-57. PubMed ID: 26476836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The State of Data Science in Genomic Nursing.
    Dreisbach C; Koleck TA
    Biol Res Nurs; 2020 Jul; 22(3):309-318. PubMed ID: 32266827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological Basis for the Clustering of Symptoms.
    Lynch Kelly D; Dickinson K; Hsiao CP; Lukkahatai N; Gonzalez-Marrero V; McCabe M; Saligan LN
    Semin Oncol Nurs; 2016 Nov; 32(4):351-360. PubMed ID: 27776832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.
    Lyon D; Elmore L; Aboalela N; Merrill-Schools J; McCain N; Starkweather A; Elswick RK; Jackson-Cook C
    Biol Res Nurs; 2014 Apr; 16(2):160-74. PubMed ID: 23585573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in symptom clusters identified using symptom occurrence rates versus severity ratings in patients with breast cancer undergoing chemotherapy.
    Ward Sullivan C; Leutwyler H; Dunn LB; Cooper BA; Paul SM; Conley YP; Levine JD; Miaskowski CA
    Eur J Oncol Nurs; 2017 Jun; 28():122-132. PubMed ID: 28478849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature.
    El Hage Chehade H; Wazir U; Mokbel K; Kasem A; Mokbel K
    Am J Surg; 2018 Jan; 215(1):171-178. PubMed ID: 28622841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast Cancer Pathology in the Era of Genomics.
    Wen HY; Collins LC
    Hematol Oncol Clin North Am; 2023 Feb; 37(1):33-50. PubMed ID: 36435613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated breast cancer genomics.
    Edgren H; Kallioniemi O
    Cancer Cell; 2006 Dec; 10(6):453-4. PubMed ID: 17157784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Educating Nursing Scientists: Integrating Genetics and Genomics into PhD Curricula.
    Barbato ES; Daly BJ; Darrah RJ
    J Prof Nurs; 2019; 35(2):89-92. PubMed ID: 30902411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer.
    Kenne Sarenmalm E; Browall M; Gaston-Johansson F
    J Pain Symptom Manage; 2014 Apr; 47(4):731-41. PubMed ID: 23916827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom clusters and quality of life in breast cancer survivors after cancer treatment in a tertiary hospital in Korea.
    Nho JH; Kim SR; Park MH; Kweon SS
    Eur J Cancer Care (Engl); 2018 Nov; 27(6):e12919. PubMed ID: 30253019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom Cluster Trajectories During Chemotherapy in Breast Cancer Outpatients.
    Hsu HT; Lin KC; Wu LM; Juan CH; Hou MF; Hwang SL; Liu Y; Dodd MJ
    J Pain Symptom Manage; 2017 Jun; 53(6):1017-1025. PubMed ID: 28196783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.